Endeavor Research private Limited is glad to announce the Conference on “Oncology Research & Cancer Diagnostics and Therapy “which is going to be held on Oct 21- 22, 2024. Oncology hosts presentations from experts across the world in the field of Oncology that create awareness and understanding of the work done by the scientists and professors working in the various fields of Oncology.
Oncology-2024 brings upon a new platform to share and discuss all the Oncology, Cancer diagnostics and therapy research. The main purpose of the webinar is to provide a platform to experts in academia and industry to showcase their current researches, latest advancements, and applications in areas pertaining to Oncology research, Cancer Diagnostics and Cancer Therapy.
Mode of Participation:
Keynote Presentations | Sessions Presentations | Young Research Forum | Delegate | Student.
Target Audiences:
Oncologists | Cancer researchers | Stem Cell researchers| Regenerative medicine researchers | Professors | Department Chairs | Assistant Professors | Associate Professors | Postdoc and Ph.D. students | Cancer therapists | Oncology and Cancer Therapy group members| CEOs and Business delegates | Oncology companies | Oncology Societies and Associations | Research Institutes and Members.
Following the unprecedented continuous conditions identified with the worldwide Coronavirus (COVID-19) flare-up, all our Oncology research works and presentations have been forcefully stopped. So we warmly invite you to contribute your most recent explore at this webinar and furthermore you will connect with the specialists from everywhere throughout the world.
We have enlisted some outstanding sessions that will give an opportunity to focus on specific areas from your own perspective experiences. Abstracts of all the related interest areas are accepted, but are not limited to the following sessions:
President CellSonic for humanity - United Kingdom
Dr. Andrew Hague’s interest in the technology that was to become CellSonic began in 1987 with the first lithotripter in Britain. Using his own capital, he developed the CellSonic VIPP machines and sold them around the world.
In 2016, Professor Hague devised the protocol for curing cancer and this is now used in CellSonic Clinics in India, Peru, Spain, and Poland. Many more are planned. There are no side effects, drugs must not be used and the cancer is stopped immediately.
CellSonic VIPP has been used for physiotherapy and sports medicine for twenty years. Where the patient also had cut skin the cure for non-healing wounds was discovered and that led to repairing nerves and pain release.
Professor Hague is the owner of CellSonic Limited and founder and chairman of CellSonic (Great Britain) Limited.
Medical Research interests
Tissue regeneration
Cancer - diagnosis and treatment
Diabetes - reversal
Alzheimer’s disease
Parkinson’s disease
Genomic analysis
The Chinese University of Hong Kong - Hong kong
The Chinese University of Hong Kong - Hong kong
University of Bath - United Kingdom
Wayne State University - USA
Case Comprehensive Cancer Center, Case Western Reserve University - United States
